抗Human B7-H1抗体(Anti-Human B7-H1 antibody)
掲載日情報:2018/11/26 現在Webページ番号:195988
Human B7-H1に対する抗体(Anti-Human B7-H1 )です。
※ 本製品は研究用です。研究用以外には使用できません。
追加しました。
価格
[在庫・価格 :2025年04月26日 12時55分現在]
詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-Human B7-H1 MAb (Clone 130021) (100 UG) |
|
10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Human B7-H1 MAb (Clone 130021) |
|
2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[在庫・価格 :2025年04月26日 12時55分現在]
Anti-Human B7-H1 MAb (Clone 130021) (100 UG)
文献数: 10
- 商品コード:MAB1561
- メーカー:RSD
- 包装:100μg
- 価格:¥104,000
- 在庫:無(未発注)
- 納期:10日程度 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
説明文 | 別名:B7-H クローン:130021 Genbank No: 29126 Protein Accession No: Q9NZQ7 |
||||||
---|---|---|---|---|---|---|---|
別包装品 | 別包装品あり | ||||||
法規制等 | |||||||
保存条件 | -20℃ | 法規備考 | |||||
抗原種 | 免疫動物 | Mouse | |||||
交差性 | Human | 適用 | FCM,IHC | ||||
標識 | Unlabeled | 性状 | Protein A/G Affinity Purified | ||||
吸収処理 | クラス | IgG | |||||
クロナリティ | Monoclonal | フォーマット | |||||
掲載カタログ |
ニュース2019年8月15日号 p.6
|
||||||
製品記事 | R&D SystemsのB7-H1/PD-L1関連製品 |
||||||
関連記事 |
Anti-Human B7-H1 MAb (Clone 130021)
文献数: 2
- 商品コード:MAB1561-SP
- メーカー:RSD
- 包装:25μg
- 価格:¥30,000
- 在庫:無(未発注)
- 納期:2~3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
追加しました。
Product Details
Species Reactivity | Human |
---|---|
Label | Unconjugated |
Immunogen | Mouse myeloma cell line NS0-derived recombinant human PD-L1/B7-H1Phe19-Thr239Accession # Q9NZQ7 |
Source | Monoclonal Mouse IgG1 Clone # 130021 |
Purification | Protein A or G purified from hybridoma culture supernatant |
Specificity | Detects human PD-L1/B7-H1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) B7-1, -2, -H2, -H3, -H3b,-H4, rhPD-L2, recombinant mouse B7-H1, recombinant rat (rr) B7-1, or rrB7-2 is observed. |
追加しました。
Applications and Data
Recommended Concentration | Sample | |
Flow Cytometry | 0.25 µg/106 cells | See below |
Immunohistochemistry | 8-25 µg/mL | See below |
CyTOF-ready | Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation. |
追加しました。
Related Product & Information
Background | PD-L1/B7-H1 |
---|---|
background_content | Background: PD-L1/B7-H1 Human B7 homolog 1 (B7-H1), also called programmed death ligand 1 (PD-L1) and programmed cell death 1 ligand 1 (PDCD1L1), is a member of the growing B7 family of immune proteins that provide signals for both stimulating and inhibiting T cell activation. Other family members include B7-1, B7-2, B7-H2, PDL2 and B7-H3. B7 proteins are members of the immunoglobulin (Ig) superfamily. Their extracellular domains contain 2 Ig-like domains and all members have short cytoplasmic domains. Among the family members, there is about 20-25% amino acid identity. Human and mouse B7-H1 share approximately 70% amino acid sequence identity. B7-H1 has been identified as one of two ligands for programmed death-1 (PD-1), a member of the CD28 family of immunoreceptors. The B7-H1 gene encodes a 291 amino acid (aa) type I membrane precursor protein with a putative 18 aa signal peptide, a 220 aa extracellular domain, a 21 aa transmembrane region, and a 31 aa cytoplasmic domain. Human B7-H1 is constitutively expressed in several organs such as heart, skeletal muscle, placenta and lung, and in lower amounts in thymus, spleen, kidney and liver. B7-H1 expression is upregulated in a small fraction of activated T and B cells and a much larger fraction of activated monocytes. B7-H1 expression is also induced in dendritic cells and keratinocytes after IFN-gamma stimulation. Interaction of B7-H1 with PD-1 results in inhibition of TCR-mediated proliferation and cytokine production. The B7-H1:PD-1 pathway is involved in the negative regulation of some immune responses and may play an important role in the regulation of peripheral tolerance. |
追加しました。
Citations
- Soluble PD-L1 as a biomarker in malignant melanoma and checkpoint blockade
Authors: J Zhou, KM Mahoney, A Giobbie-Hu, F Zhao, S Lee, X Liao, S Rodig, J Li, X Wu, LH Butterfiel, M Piesche, MP Manos, LM Eastman, G Dranoff, GJ Freeman, FS Hodi
Cancer Immunol Res, 2017;0(0):.
Species: Human
Sample Type: Plasma
Application: ELISA Capture - Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
Authors: SF Kammerer-J, A Brunot, K Bensalah, B Campillo-G, M Lefort, S Bayat, A Ravaud, F Dupuis, M Yacoub, G Verhoest, B Peyronnet, R Mathieu, A Lespagnol, J Mosser, J Edeline, B Laguerre, JC Bernhard, N Rioux-Lecl
Urol. Oncol., 2017;0(0):.
Species: Human
Sample Type: Whole Cells
Application: IHC-P - Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.
Authors: Song, Xiao, Liu, Junwei, Lu, Yi, Jin, Hongchua, Huang, Dongshen
Oncol Rep, 2014;31(3):1191-8.
Species: Human
Sample Type: Whole Tissue
Application: IHC - IFN-gamma generates maturation-arrested dendritic cells that induce T cell hyporesponsiveness independent of Foxp3+ T-regulatory cell generation.
Authors: Rojas D, Krishnan R,
Immunol. Lett., 2010;132(1):31-7.
Species: Human
Sample Type: Whole Cells
Application: Flow
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。